JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

Search

Evolent Health Inc

Aperta

SettoreSettore sanitario

3.26 -2.4

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

3.3

Massimo

3.4699999999999998

Metriche Chiave

By Trading Economics

Entrata

30M

-21M

Vendite

35M

480M

Margine di Profitto

-4.351

Dipendenti

4,500

EBITDA

512K

15M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+151.48% upside

Dividendi

By Dow Jones

Utili prossimi

19 feb 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-349M

430M

Apertura precedente

5.66

Chiusura precedente

3.26

Notizie sul Sentiment di mercato

By Acuity

25%

75%

47 / 352 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Very Strong Bullish Evidence

Evolent Health Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

27 gen 2026, 23:07 UTC

Utili

Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into 1Q -- Update

27 gen 2026, 21:27 UTC

Utili

Texas Instruments 4Q Sales Rise, Profit Falls

27 gen 2026, 23:55 UTC

Discorsi di Mercato

Yen Weakens Slightly on Possible Technical Correction -- Market Talk

27 gen 2026, 23:47 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

27 gen 2026, 23:47 UTC

Discorsi di Mercato

Nikkei May Decline Amid Caution Over Earnings -- Market Talk

27 gen 2026, 23:39 UTC

Discorsi di Mercato

Gold Falls on Likely Technical Correction, Possible Profit-Taking -- Market Talk

27 gen 2026, 23:20 UTC

Utili

SK Innovation: Asset-Impairment Losses Weighed on Earnings

27 gen 2026, 23:20 UTC

Utili

SK Innovation: Industry Downturn, Narrower Profit Margins Weighed on Earnings

27 gen 2026, 23:19 UTC

Utili

SK Innovation Posts Net Loss for Second Consecutive Year

27 gen 2026, 23:19 UTC

Utili

SK Innovation 2025 Loss KRW5.406T Vs. Loss KRW2.372T >096770.SE

27 gen 2026, 23:18 UTC

Utili

SK Innovation 2025 Oper Pft KRW448.07B Vs. Pft KRW356.07B >096770.SE

27 gen 2026, 23:18 UTC

Utili

SK Innovation 2025 Rev KRW80.296T Vs. KRW74.243T >096770.SE

27 gen 2026, 23:11 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

27 gen 2026, 23:11 UTC

Discorsi di Mercato

Alkane Resources Bull Positive on Outlook in Red-Hot Gold Market -- Market Talk

27 gen 2026, 23:07 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Freightways's Australian M&A Adds Ballast to Bull's View -- Market Talk

27 gen 2026, 22:17 UTC

Discorsi di Mercato

U.S. Dollar Slips Following Trump Comments -- Market Talk

27 gen 2026, 22:06 UTC

Utili

Boeing's Stepped-Up Plane Deliveries Lift Sales -- Update

27 gen 2026, 21:51 UTC

Utili

Texas Instruments Stock Jumps on Strong Outlook -- Barrons.com

27 gen 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

27 gen 2026, 21:43 UTC

Utili

RTX Stock Jumps After Earnings. It Has 'Great Momentum,' Says CEO. -- Barrons.com

27 gen 2026, 21:41 UTC

Utili

GM Lost Billions on EVs, Still Beat Wall Street's Expectations -- 5th Update

27 gen 2026, 21:38 UTC

Utili

These Stocks Are Today's Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More -- Barrons.com

27 gen 2026, 21:32 UTC

Utili

Ampol: Modest Profit From F&I International in 2025

27 gen 2026, 21:32 UTC

Utili

Ampol: F&I Australia Ebit Up by High Single Digit Percent in 2025

27 gen 2026, 21:31 UTC

Utili

Ampol: New Zealand Ebit in 2025 In Line With Prior Year

27 gen 2026, 21:31 UTC

Utili

Ampol: Australia Convenience Retail Ebit Up Mid-Single Digit Percent in 2025

27 gen 2026, 21:30 UTC

Utili

Ampol 4Q Lytton Refinery Production 1.56 Billion Liters

27 gen 2026, 21:29 UTC

Utili

Ampol FY Unaudited Replacement-Cost Ebitda A$1.44 Billion

27 gen 2026, 21:29 UTC

Utili

Ampol FY Unaudited Replacement-Cost Operating Profit A$945 Million

27 gen 2026, 21:28 UTC

Utili

Ampol 4Q Lytton Refiner Margin US$15.14/Bbl

Confronto tra pari

Modifica del prezzo

Evolent Health Inc Previsione

Obiettivo di Prezzo

By TipRanks

151.48% in crescita

Previsioni per 12 mesi

Media 9.33 USD  151.48%

Alto 16 USD

Basso 5 USD

Basato su 14 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Evolent Health Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

14 ratings

13

Acquista

1

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

10.33 / 10.95Supporto e resistenza

A breve termine

Very Strong Bullish Evidence

A termine intermedio

Very Strong Bullish Evidence

A lungo termine

Weak Bearish Evidence

Sentiment

By Acuity

47 / 352 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
help-icon Live chat